中财网 中财网股票行情
荣昌生物(688331)财务分析指标    年份：
截止日期2025-03-312024-12-312024-09-302024-06-302024-03-31
营业总收入(万元)52596.86171686.17120887.4374175.6833043.48
营业收入(万元)52596.86171686.17120887.4374175.6833043.48
营业总成本(万元)77936.90324789.26231624.47155761.8868245.35
营业成本(万元)8803.0833716.3524474.4916119.197435.97
净利润(万元)-24215.15-149923.89-111379.30-80645.32-37220.43
归属于母公司的净利润(万元)-25414.45-146836.08-107142.66-78045.98-34892.17
营业利润(万元)-24974.65-145565.54-105586.18-77154.81-34494.89
利润总额(万元)-25414.45-146836.08-107142.66-78045.98-34892.17
少数股东损益(万元)----------
基本每股收益(元)-0.46(元)-2.73(元)-1.99(元)-1.45(元)-0.65(元)
稀释每股收益(元)-0.46(元)-2.73(元)-1.99(元)-1.45(元)-0.65(元)
非经常性损益(万元)-208.523928.16--1341.39-334.55
扣除非经常性损益后净利润(万元)-25205.92-150764.24-109739.38-79387.36-34557.62
总资产(万元)530734.50549851.82571271.34575453.90547865.69
总负债(万元)353592.00351231.75334403.29308992.95240010.47
归属于母公司股东权益合计(万元)177142.51198620.06236868.05266460.95307855.22
股东权益合计(万元)177142.51198620.06236868.05266460.95307855.22
实收资本(股本)(万元)54433.2154433.2154433.2154433.2154433.21
资本公积(万元)628194.63629098.99628759.06626944.35625164.06
未分配利润(万元)-457601.57-432187.12-392493.70-363397.02-320243.21
经营活动产生的现金流量净额(万元)-18831.51-111430.35-83510.31-82016.95-42628.99
经营活动现金流入小计(万元)47999.99163249.99122217.2663360.6528912.87
经营活动现金流出小计(万元)66831.50274680.34205727.57145377.6071541.87
投资活动产生的现金流量净额(万元)-2678.79-24823.51-42580.65-33457.10-8136.25
投资活动现金流入小计(万元)15985.10102379.6854089.521399.681401.72
投资活动现金流出小计(万元)18663.89127203.1996670.1634856.789537.96
筹资活动产生的现金流量净额(万元)17672.40139296.88120205.84109949.5540198.77
筹资活动现金流入小计(万元)53069.65180560.52131662.53117664.5944200.47
筹资活动现金流出小计(万元)35397.2641263.6411456.697715.034001.71
期末现金及现金等价物余额(万元)71878.3075953.0066200.6267314.2161973.26
最后修改日期2025-04-292025-03-282024-10-302024-08-192024-04-27
↑返回页顶↑

转至荣昌生物（688331）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。